Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry

Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic... J Cancer Res Clin Oncol (2017) 143:1701–1712 DOI 10.1007/s00432-017-2428-0 ORIGINAL ARTICLE – CANCER RESEARCH Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post‑metastatic survival: 35‑year results from the Munich Cancer Registry 1 1 2 3 4 5 6 Dieter Hölzel · Renate Eckel · Ingo Bauerfeind · Bernd Baier · Thomas Beck · Michael Braun · Johannes Ettl · 5 6 7 8 3 9 Ulrich Hamann · Marion Kiechle · Sven Mahner · Christian Schindlbeck · Johann de Waal · Nadia Harbeck · Jutta Engel Received: 12 April 2017 / Accepted: 13 April 2017 / Published online: 20 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract of liver and CNS METs has more than doubled, the rate of Purpose Systemic therapies (ATHs) in early breast cancer lung METs remains stable, and the rate of bone METs has have improved the survival of breast cancer (BC) patients been reduced by approximately 50%. MFS has been pro- in recent decades. The magnitude of the changes in overall, longed with a hazard ratio 0.75 (P < 0.0001), but PMS has metastasis-free (MFS) and post-metastatic (PMS) survival declined (hazard ratio 1.36; P < 0.0001); however, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Research and Clinical Oncology Springer Journals

Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry

Loading next page...
 
/lp/springer_journal/improved-systemic-treatment-for-early-breast-cancer-improves-cure-F7utwlUXmD
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Cancer Research; Internal Medicine; Hematology
ISSN
0171-5216
eISSN
1432-1335
D.O.I.
10.1007/s00432-017-2428-0
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial